Assignee
NANJING SINOGEN BIOTECH & PHARMACEUTICAL INC
CN·3 granted patents·1 pending application·5 citations·filing 2014–2016
Top patents by PatentIndex Score
4 records- 0176US9816083B2Genetically engineered bacterium for treatment of breast cancer, method for constructing the bacterium, and applications thereofNANJING SINOGEN BIOTECH & PHARMACEUTICAL INC·Filed 2014·Granted Nov 14, 2017·3 cites·4 claims
- 0276US9439934B1Application of an attenuated salmonella typhimurium, its genetically engineered bacterium in preparing drugs for the treatment of prostate cancerNANJING SINOGEN BIOTECH & PHARMACEUTICAL INC·Filed 2015·Granted Sep 13, 2016·2 cites·5 claims
- 0340US10113184B2Microbe transformant for weight loss and lipid reduction, the method for constructing the transformant, and application thereofNANJING SINOGEN BIOTECH & PHARMACEUTICAL INC·Filed 2016·Granted Oct 30, 2018·0 cites·5 claims
- 0438US2018339032A1Application of genetically genineered bacterium of attenuated salmonella typhimurium in preparation of medicine for treatment of liver cancerNANJING SINOGEN BIOTECH & PHARMACEUTICAL INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NANJING SINOGEN BIOTECH & PHARMACEUTICAL INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →